Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.

NCT00531206 · clinicaltrials.gov ↗

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tipranavir
DRUG: Ritonavir

Sponsor

Boehringer Ingelheim